top of page

Selling Behavioral Health, Mental Health, & ABA Therapy

Behavioral Health, Mental Health

Behavioral and mental health services are becoming increasingly important in the healthcare industry due to rising awareness and demand for mental health care. These practices specially those with a telemedicine components are prime targets for acquisition by larger healthcare providers and investors focused on expanding their behavioral health offerings.

Frequently Asked Questions

How are Behavioral Health or Mental Health Companies are Valued?

There are number of valuation methods that can be used in determining the valuation of your company. The most common is based on the top line revenue, bottom line adjusted EBITDA and a multiplier based on market conditions. To get a free and confidential valuation of your company, fill out the form, and one our managing directors will be able to provide you a current market valuation for your company.

How long will it take for me to sell my behavioral and mental health practices to a potential buyer or an investor?

It is generally a 4-6 month process from the time we receive all the information we need from you to go to market.

Who are the typical buyers for behavioral and mental health practices?

Larger healthcare networks, private equity firms, and individual practitioners.

What are the challenges in selling a behavioral or mental health practice?

Ensuring continuity of care and maintaining patient relationships can be challenging.

What factors determine the value of a behavioral or mental health practice?

Valuation depends on patient volume, types of services offered, and the reputation of the practice.

Active Listings

$2.5 Million EBITDA Provider of Medical Services for Behavioral Health Hospitals in Texas

State:

Texas

Category:

Behavioral Health, Mental Health, & ABA Therapy

Revenue

$7,800,000

Asking Price:

$20,000,000

Listing Code:

TXBH1J

$500,000 EBITDA Outpatient Psychotherapy Practice in New England

State:

Not Disclosed

Category:

Behavioral Health, Mental Health, & ABA Therapy

Revenue

-

Asking Price:

$3,000,000

Listing Code:

XYBH2F

Growing and Profitable Mental Health Clinics in Idaho

State:

Idaho

Category:

Behavioral Health, Mental Health, & ABA Therapy

Revenue

$3,600,000

Asking Price:

$2,500,000

Listing Code:

IDBH1C

Leading Multi-State Provider of Pediatric ABA Therapy

State:

Not Disclosed

Category:

Behavioral Health, Mental Health, & ABA Therapy

Revenue

$6,700,000

Asking Price:

$10,000,000

Listing Code:

XYBH2D

Center Based Pediatric ABA Therapy Company in New Jersey

State:

New Jersey

Category:

Behavioral Health, Mental Health, & ABA Therapy

Revenue

$2,500,000

Asking Price:

-

Listing Code:

NJBH1B

$1.8 Million Revenue ABA Therapy Company in West Central Florida

State:

Florida

Category:

Behavioral Health, Mental Health, & ABA Therapy

Revenue

$1,800,000

Asking Price:

$2,000,000

Listing Code:

FLBH1K

Currently, there are no available listings. We are actively seeking new opportunities for our buyers and investors. Please contact us for more information

Contact the Team

Jack Eskenazi American Healthcare Capital

Jack Eskenazi

President/Founder

American HealthCare Capital

Dr. Allen Nazeri DDS MBA.jpg

Dr. Allen Nazeri 

Managing Partner

PRIME exits

Join our mailing list to receive our latest news, and listings

About us
 

PRIME exits® is a registered trademark of Nazeri & Company LLC, an independent affiliate of American Healthcare Capital. Nazeri & Company Co., Ltd. (Thailand) operates as a separate and independent entity, providing marketing and content creation services. PRIME exits® is a specialized merger and acquisition advisory firm dedicated to the healthcare industry, supported by a network of over 50 M&A analysts and advisors.

 

Locations

Los Angeles

Las Vegas

Bangkok

Vancouver, BC

Milan, Italy

Contact us

 

1-800- 424-3388 HEAD OFFICE

1-310-625-7889 Jack Eskenazi

1-702-506-3392 Dr. Allen Nazeri 

Valuation Team

Jack@ahcteam.com

Allen@ahcteam.com

Allen@pexits.com

PRIME exits M&A Bio Barcode
bottom of page